Yale Podnos Biography and Net Worth

Director of Oncology Institute


A native of Southern California, Yale D. Podnos, M.D., MPH, FACS, attended New York University, graduating with a degree in biology. He attended graduate school at the Harvard School of Public Health and medical school at the University of California, Irvine School of Medicine, where he also completed his residency in general surgery.

After his residency, he completed a fellowship in surgical oncology at the City of Hope. After training, Dr. Podnos joined the faculty at Duke University and later became the Chairman of the Department of Surgery and Director of Surgical Oncology at UNC Rex Healthcare in Raleigh, NC.

In practice, his specialties are surgical care of patients with pancreatic, hepatobiliary, melanoma, and esophagus cancers. He has authored over 60 scientific publications.

What is Yale Podnos' net worth?

The estimated net worth of Yale Podnos is at least $255.33 thousand as of March 26th, 2025. Dr. Podnos owns 79,049 shares of Oncology Institute stock worth more than $255,328 as of December 5th. This net worth evaluation does not reflect any other assets that Dr. Podnos may own. Additionally, Dr. Podnos receives a salary of $535,360.00 as Director at Oncology Institute. Learn More about Yale Podnos' net worth.

How old is Yale Podnos?

Dr. Podnos is currently 52 years old. There are 4 older executives and no younger executives at Oncology Institute. The oldest executive at Oncology Institute is Mr. Richard Alan Barasch, Chairman of the Board, who is 70 years old. Learn More on Yale Podnos' age.

What is Yale Podnos' salary?

As the Director of The Oncology Institute, Inc., Dr. Podnos earns $535,360.00 per year. The highest earning executive at Oncology Institute is Dr. Daniel Virnich FACHE, M.D., MBA, Chief Executive Officer, who commands a salary of $614,620.00 per year. Learn More on Yale Podnos' salary.

How do I contact Yale Podnos?

The corporate mailing address for Dr. Podnos and other Oncology Institute executives is 345 PARK AVENUE SOUTH, NEW YORK NY, 10010. Oncology Institute can also be reached via phone at 562-735-3226 and via email at [email protected]. Learn More on Yale Podnos' contact information.

Has Yale Podnos been buying or selling shares of Oncology Institute?

Yale Podnos has not been actively trading shares of Oncology Institute in the last ninety days. Most recently, on Wednesday, March 26th, Yale Podnos bought 9,056 shares of Oncology Institute stock. The stock was acquired at an average cost of $1.04 per share, with a total value of $9,418.24. Following the completion of the transaction, the insider now directly owns 79,049 shares of the company's stock, valued at $82,210.96. Learn More on Yale Podnos' trading history.

Who are Oncology Institute's active insiders?

Oncology Institute's insider roster includes Yale Podnos (Director), and Daniel Virnich (CEO). Learn More on Oncology Institute's active insiders.

Are insiders buying or selling shares of Oncology Institute?

In the last year, Oncology Institute insiders bought shares 3 times. They purchased a total of 122,258 shares worth more than $127,148.32. In the last year, insiders at the sold shares 8 times. They sold a total of 11,476,137 shares worth more than $34,282,013.19. The most recent insider tranaction occured on November, 18th when Director Mark L Pacala sold 50,000 shares worth more than $200,000.00. Insiders at Oncology Institute own 8.5% of the company. Learn More about insider trades at Oncology Institute.

Information on this page was last updated on 11/18/2025.

Yale Podnos Insider Trading History at Oncology Institute

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/26/2025Buy9,056$1.04$9,418.2479,049View SEC Filing Icon  
See Full Table

Yale Podnos Buying and Selling Activity at Oncology Institute

This chart shows Yale Podnos's buying and selling at Oncology Institute by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Oncology Institute Company Overview

Oncology Institute logo
The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.
Read More

Today's Range

Now: $3.23
Low: $3.06
High: $3.32

50 Day Range

MA: $3.75
Low: $2.94
High: $4.75

2 Week Range

Now: $3.23
Low: $0.17
High: $4.88

Volume

2,000,460 shs

Average Volume

3,045,784 shs

Market Capitalization

$317.77 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.16